CMG Pharmaceutical, a subsidiary of Chabiotech, is collaborating with a major animal hospital to develop pet health care products.
On October 21, CMG Pharmaceutical announced that it has signed a memorandum of understanding (MOU) with SKY Animal Medical Center for the joint development and business cooperation of pet health care products. The two companies will work together to develop and produce products that combine colostrum exosome ingredients with existing materials, focusing on nutritional supplements for the liver, pancreas, and kidney health of pets.
CMG Pharmaceutical will handle the sourcing, production, and regulatory approval of the ingredients and products. SKY Animal Medical Center will provide expertise based on its veterinary experience, advising on product formulation ratios and managing marketing and distribution.
The colostrum exosomes used in the products are functional materials developed by the Chaimed Research Institute (CHARI) of the Chabiotech Group, utilizing extracellular vesicle (EV) separation and purification technology. Colostrum is the initial milk secreted by mothers immediately after giving birth, containing various bioactive components, including immunoglobulins. Exosomes are tiny particles secreted by cells that carry proteins, lipids, and nucleic acids, playing a role in intercellular communication. CMG Pharmaceutical recently received approval for its colostrum exosome ingredients and has established facilities for colostrum separation and purification.
With this agreement, CMG Pharmaceutical plans to expand its veterinary-exclusive product line under the brand 'Chaore' and enhance its portfolio of professional products. SKY Animal Medical Center has been operating branches in major regions across the country, starting with its Bucheon location in 2011, and now includes Incheon, Suwon, and Cheonan.
Lee Joo-hyung, CEO of CMG Pharmaceutical, stated, "As the pet health care market grows, it is becoming increasingly important to combine the research and development capabilities of the pharmaceutical and bio sectors with the expertise of veterinary medicine."
Meanwhile, CMG Pharmaceutical is accelerating the commercialization of three next-generation functional new materials. The company is pursuing research and development and productization of these materials in collaboration with the Chaimed Research Institute (CHARI), including 'Corydalis Tuber Extract' for cognitive function improvement, 'Phytoestrogens' for women's menopausal health, and 'Colostrum Exosomes (EV)' for pet health care.
On October 21, CMG Pharmaceutical announced that it has signed a memorandum of understanding (MOU) with SKY Animal Medical Center for the joint development and business cooperation of pet health care products. The two companies will work together to develop and produce products that combine colostrum exosome ingredients with existing materials, focusing on nutritional supplements for the liver, pancreas, and kidney health of pets.
CMG Pharmaceutical will handle the sourcing, production, and regulatory approval of the ingredients and products. SKY Animal Medical Center will provide expertise based on its veterinary experience, advising on product formulation ratios and managing marketing and distribution.
The colostrum exosomes used in the products are functional materials developed by the Chaimed Research Institute (CHARI) of the Chabiotech Group, utilizing extracellular vesicle (EV) separation and purification technology. Colostrum is the initial milk secreted by mothers immediately after giving birth, containing various bioactive components, including immunoglobulins. Exosomes are tiny particles secreted by cells that carry proteins, lipids, and nucleic acids, playing a role in intercellular communication. CMG Pharmaceutical recently received approval for its colostrum exosome ingredients and has established facilities for colostrum separation and purification.
With this agreement, CMG Pharmaceutical plans to expand its veterinary-exclusive product line under the brand 'Chaore' and enhance its portfolio of professional products. SKY Animal Medical Center has been operating branches in major regions across the country, starting with its Bucheon location in 2011, and now includes Incheon, Suwon, and Cheonan.
Lee Joo-hyung, CEO of CMG Pharmaceutical, stated, "As the pet health care market grows, it is becoming increasingly important to combine the research and development capabilities of the pharmaceutical and bio sectors with the expertise of veterinary medicine."
Meanwhile, CMG Pharmaceutical is accelerating the commercialization of three next-generation functional new materials. The company is pursuing research and development and productization of these materials in collaboration with the Chaimed Research Institute (CHARI), including 'Corydalis Tuber Extract' for cognitive function improvement, 'Phytoestrogens' for women's menopausal health, and 'Colostrum Exosomes (EV)' for pet health care.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.